I blogged about how CytoDyn is currently researching their antibody therapy on mild to moderate COVID-19 cases. According to this article, they just filed to move ahead & treat those patients whose cases are severe & most likely terminal. The paper suggests that the approach has promise. Here's hoping.
Take care.
Cya...
PS - I forgot to say, we had our 1st mowing March 31st. Mine April was an allergy-fest. The mowing begins.
No comments:
Post a Comment